VLA1553

· Valneva Austria GmbH

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for VLA1553, covering 2024-12-02 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Results: A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years [Phase 2]